tiprankstipranks
Illumina (ILMN)
NASDAQ:ILMN
US Market

Illumina (ILMN) Stock Forecast & Price Target

4,623 Followers
See the Price Targets and Ratings of:

ILMN Analyst Ratings

Hold
11Ratings
Hold
4 Buy
5 Hold
2 Sell
Based on 11 analysts giving stock ratings to
Illumina
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ILMN Stock 12 Month Forecast

Average Price Target

$136.33
▲(7.66% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $136.33 with a high forecast of $170.00 and a low forecast of $85.00. The average price target represents a 7.66% change from the last price of $126.63.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"75":"$75","99":"$99","123":"$123","147":"$147","171":"$171"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":170,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$170.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":136.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$136.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$85.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[75,99,123,147,171],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,126.63,129.96615384615384,133.3023076923077,136.63846153846154,139.9746153846154,143.31076923076924,146.6469230769231,149.9830769230769,153.31923076923076,156.6553846153846,159.99153846153845,163.3276923076923,166.66384615384615,{"y":170,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,126.63,127.37615384615384,128.1223076923077,128.86846153846153,129.61461538461538,130.36076923076922,131.10692307692307,131.85307692307694,132.5992307692308,133.34538461538463,134.09153846153848,134.83769230769232,135.58384615384617,{"y":136.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,126.63,123.4276923076923,120.22538461538461,117.02307692307691,113.82076923076923,110.61846153846153,107.41615384615385,104.21384615384615,101.01153846153846,97.80923076923077,94.60692307692307,91.40461538461538,88.2023076923077,{"y":85,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":78.39,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.51,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.09,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.15,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.66,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.82,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.26,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.54,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":128.72,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":131.16,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":141.13,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.89,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.63,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$170.00Average Price Target$136.33Lowest Price Target$85.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen
$140$117.67
Hold
-7.08%
Downside
Reiterated
03/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Illumina (NASDAQ: ILMN), Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and Monopar Therapeutics Inc (NASDAQ: MNPR)
Canaccord Genuity Analyst forecast on ILMN
Canaccord Genuity
Canaccord Genuity
$150
Hold
18.46%
Upside
Reiterated
03/23/26
Illumina: Neutral Stance Amid Emerging Roche Competition and Incremental NovaSeq X Enhancements
Bank of America Securities Analyst forecast on ILMN
Bank of America Securities
Bank of America Securities
$85
Sell
-32.88%
Downside
Reiterated
03/02/26
Bank of America Securities Reaffirms Their Sell Rating on Illumina (ILMN)
Guggenheim Analyst forecast on ILMN
Guggenheim
Guggenheim
$170
Buy
34.25%
Upside
Reiterated
02/23/26
Guggenheim Keeps Their Buy Rating on Illumina (ILMN)
Piper Sandler Analyst forecast on ILMN
Piper Sandler
Piper Sandler
$195$170
Buy
34.25%
Upside
Reiterated
02/09/26
Analysts Are Bullish on Top Healthcare Stocks: Illumina (ILMN), Veeva Systems (VEEV)
UBS
$120$135
Hold
6.61%
Upside
Reiterated
02/06/26
Illumina price target raised to $135 from $120 at UBSIllumina price target raised to $135 from $120 at UBS
Robert W. Baird
$132$137
Hold
8.19%
Upside
Reiterated
02/06/26
Illumina price target raised to $137 from $132 at BairdIllumina price target raised to $137 from $132 at Baird
Evercore ISI Analyst forecast on ILMN
Evercore ISI
Evercore ISI
$155$150
Buy
18.46%
Upside
Reiterated
02/06/26
Illumina price target lowered to $150 from $155 at Evercore ISIIllumina price target lowered to $150 from $155 at Evercore ISI
Stifel Nicolaus Analyst forecast on ILMN
Stifel Nicolaus
Stifel Nicolaus
$155
Buy
22.40%
Upside
Reiterated
02/06/26
Illumina (ILMN) Gets a Buy from Stifel Nicolaus
J.P. Morgan Analyst forecast on ILMN
J.P. Morgan
J.P. Morgan
$130$120
Hold
-5.24%
Downside
Reiterated
02/06/26
Illumina price target lowered to $120 from $130 at JPMorganIllumina price target lowered to $120 from $130 at JPMorgan
Barclays Analyst forecast on ILMN
Barclays
Barclays
$110
Sell
-13.13%
Downside
Reiterated
02/06/26
Illumina (ILMN) Gets a Sell from Barclays
Citi
$80$40.5
Sell
-68.02%
Downside
Reiterated
01/02/26
Citi Reaffirms Their Sell Rating on Illumina (ILMN)
Jefferies Analyst forecast on ILMN
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$108$125
Hold
-1.29%
Downside
Reiterated
12/17/25
Jefferies Sticks to Its Hold Rating for Illumina (ILMN)
RBC Capital Analyst forecast on ILMN
RBC Capital
RBC Capital
$126$124
Buy
-2.08%
Downside
Reiterated
09/02/25
Illumina (ILMN) Receives a Buy from RBC Capital
Daiwa
$94
Hold
-25.77%
Downside
Downgraded
08/12/25
Illumina downgraded to Neutral from Outperform at DaiwaIllumina downgraded to Neutral from Outperform at Daiwa
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen
$140$117.67
Hold
-7.08%
Downside
Reiterated
03/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Illumina (NASDAQ: ILMN), Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and Monopar Therapeutics Inc (NASDAQ: MNPR)
Canaccord Genuity Analyst forecast on ILMN
Canaccord Genuity
Canaccord Genuity
$150
Hold
18.46%
Upside
Reiterated
03/23/26
Illumina: Neutral Stance Amid Emerging Roche Competition and Incremental NovaSeq X Enhancements
Bank of America Securities Analyst forecast on ILMN
Bank of America Securities
Bank of America Securities
$85
Sell
-32.88%
Downside
Reiterated
03/02/26
Bank of America Securities Reaffirms Their Sell Rating on Illumina (ILMN)
Guggenheim Analyst forecast on ILMN
Guggenheim
Guggenheim
$170
Buy
34.25%
Upside
Reiterated
02/23/26
Guggenheim Keeps Their Buy Rating on Illumina (ILMN)
Piper Sandler Analyst forecast on ILMN
Piper Sandler
Piper Sandler
$195$170
Buy
34.25%
Upside
Reiterated
02/09/26
Analysts Are Bullish on Top Healthcare Stocks: Illumina (ILMN), Veeva Systems (VEEV)
UBS
$120$135
Hold
6.61%
Upside
Reiterated
02/06/26
Illumina price target raised to $135 from $120 at UBSIllumina price target raised to $135 from $120 at UBS
Robert W. Baird
$132$137
Hold
8.19%
Upside
Reiterated
02/06/26
Illumina price target raised to $137 from $132 at BairdIllumina price target raised to $137 from $132 at Baird
Evercore ISI Analyst forecast on ILMN
Evercore ISI
Evercore ISI
$155$150
Buy
18.46%
Upside
Reiterated
02/06/26
Illumina price target lowered to $150 from $155 at Evercore ISIIllumina price target lowered to $150 from $155 at Evercore ISI
Stifel Nicolaus Analyst forecast on ILMN
Stifel Nicolaus
Stifel Nicolaus
$155
Buy
22.40%
Upside
Reiterated
02/06/26
Illumina (ILMN) Gets a Buy from Stifel Nicolaus
J.P. Morgan Analyst forecast on ILMN
J.P. Morgan
J.P. Morgan
$130$120
Hold
-5.24%
Downside
Reiterated
02/06/26
Illumina price target lowered to $120 from $130 at JPMorganIllumina price target lowered to $120 from $130 at JPMorgan
Barclays Analyst forecast on ILMN
Barclays
Barclays
$110
Sell
-13.13%
Downside
Reiterated
02/06/26
Illumina (ILMN) Gets a Sell from Barclays
Citi
$80$40.5
Sell
-68.02%
Downside
Reiterated
01/02/26
Citi Reaffirms Their Sell Rating on Illumina (ILMN)
Jefferies Analyst forecast on ILMN
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$108$125
Hold
-1.29%
Downside
Reiterated
12/17/25
Jefferies Sticks to Its Hold Rating for Illumina (ILMN)
RBC Capital Analyst forecast on ILMN
RBC Capital
RBC Capital
$126$124
Buy
-2.08%
Downside
Reiterated
09/02/25
Illumina (ILMN) Receives a Buy from RBC Capital
Daiwa
$94
Hold
-25.77%
Downside
Downgraded
08/12/25
Illumina downgraded to Neutral from Outperform at DaiwaIllumina downgraded to Neutral from Outperform at Daiwa
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

3 Months
xxx
Success Rate
20/38 ratings generated profit
53%
Average Return
+2.71%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 52.63% of your transactions generating a profit, with an average return of +2.71% per trade.
1 Year
Michael RyskinBank of America Securities
Success Rate
15/24 ratings generated profit
63%
Average Return
+2.15%
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +2.15% per trade.
2 Years
xxx
Success Rate
18/31 ratings generated profit
58%
Average Return
+0.38%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 58.06% of your transactions generating a profit, with an average return of +0.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ILMN Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
1
1
0
0
0
Buy
5
5
9
9
5
Hold
12
6
12
12
10
Sell
10
5
6
5
4
Strong Sell
0
1
1
1
0
total
28
18
28
27
19
In the current month, ILMN has received 5 Buy Ratings, 10 Hold Ratings, and 4 Sell Ratings. ILMN average Analyst price target in the past 3 months is 136.33.
Each month's total comprises the sum of three months' worth of ratings.

ILMN Financial Forecast

ILMN Earnings Forecast

Next quarter’s earnings estimate for ILMN is $1.06 with a range of $1.04 to $1.14. The previous quarter’s EPS was $1.35. ILMN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.
Next quarter’s earnings estimate for ILMN is $1.06 with a range of $1.04 to $1.14. The previous quarter’s EPS was $1.35. ILMN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.

ILMN Sales Forecast

Next quarter’s sales forecast for ILMN is $1.07B with a range of $1.06B to $1.08B. The previous quarter’s sales results were $1.16B. ILMN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.
Next quarter’s sales forecast for ILMN is $1.07B with a range of $1.06B to $1.08B. The previous quarter’s sales results were $1.16B. ILMN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.

ILMN Stock Forecast FAQ

What is ILMN’s average 12-month price target, according to analysts?
Based on analyst ratings, Illumina’s 12-month average price target is 136.33.
    What is ILMN’s upside potential, based on the analysts’ average price target?
    Illumina has 7.66% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ILMN a Buy, Sell or Hold?
          Illumina has a consensus rating of Hold which is based on 4 buy ratings, 5 hold ratings and 2 sell ratings.
            What is Illumina’s price target?
            The average price target for Illumina is 136.33. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $170.00 ,the lowest forecast is $85.00. The average price target represents 7.66% Increase from the current price of $126.63.
              What do analysts say about Illumina?
              Illumina’s analyst rating consensus is a Hold. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of ILMN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.